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Here we determine the sequence specificity of DNA
binding by CBF and analyze the phosphate contacts made by
CBF on the DNA backbone. To determine the sequence
preferences at each position of the binding site for CBF, we
performed selected and amplified binding sequence (SAAB)
footprinting (2). The DNA template for SAAB footprinting
contained three guanines conserved in all core sites found in
mammalian type C retroviral enhancers (Fig. 1) (5). These
guanines were identified by methylation interference analyses as critical contacts for CBF and SEFi binding (17, 19).
The conserved guanines were flanked by randomly specified
positions (N), which were in turn flanked by conserved
sequences for the purpose of annealing oligonucleotide primers (primers A and B) for polymerase chain reaction (PCR);
these conserved flanking sequences also contained restriction sites for BamHI and EcoRI endonucleases. A control
template that contained the corresponding sequence from
the Mo-MuLV enhancer between the conserved PCR primer
binding sites was synthesized. The sequences of the random
oligonucleotide and primers are shown in Fig. 1. All oligonucleotides were synthesized by Operon Technology, Inc.
The random and control DNA templates were purified by
high-pressure liquid chromatography. A total of 100 pmol of
primer A was end-labeled with [y-32P]ATP (7,000 Ci/mmol;
ICN) and T4 polynucleotide kinase (New England Biolabs).
Double-stranded template was generated by PCR with 100
pmol of 32P-end-labeled primer A, 100 pmol of primer B, and
10 pmol of the random or control template according to the
instructions provided by the manufacturer (Perkin-Elmer
Cetus). Reactions were incubated at 94°C (1 min), 37°C (1
min), and 72°C (1 min) for 30 cycles and at 72°C (7 min).
Double-stranded probes were purified by electrophoresis
through a 12% native polyacrylamide gel and eluted from the
gel by electrophoresis onto an NA45 membrane (Schleicher
and Schuell) (1). The specific activity of the probe was
approximately 106 cpm/pmol.
Electrophoretic mobility shift assays were performed as
previously described, with 5 RI of affinity purified CBF and
random or control probe in the binding reaction mixtures
(10,000 cpm per reaction mixture) (19). The position of the
protein-DNA complex in the random probe, which cannot be
seen, was estimated from the position of the protein-DNA
complex in the control probe (data not shown). DNA from
the protein-DNA complex in the random probe was eluted
from dried gels in elution buffer (0.5 M ammonium acetate,
10 mM magnesium acetate, 1 mM EDTA, and 0.1% sodium

The core site is a sequence motif present in the enhancers
of many mammalian type C retroviruses (5). It is an important genetic determinant of pathogenesis of two retroviruses,
the Moloney murine leukemia virus (Mo-MuLV) and the
SL3-3 MuLV. A 2-bp mutation in both of the core sites in
Mo-MuLV increases the latent period of leukemia caused by
the Moloney virus and shifts the specificity of the disease
from thymic leukemia to erythroid leukemia (15). A 3-bp
mutation in each of the four core sites in the SL3-3 MuLV
renders that virus nonleukemogenic (7).
Although the core site is present in all mammalian type C
retroviral enhancers, the sequences of these core sites vary
between independent virus isolates. A comparison of enhancer sequences from 35 independent full-length integrated
proviruses of ecotropic, xenotropic, amphotropic, and polytropic host ranges identified bases at several positions in the
core site common to all enhancers (TGPyGGTN). It has
been proposed that variability at the pyrimidine (TGPyG
GTN) and at position N (TGPyGGTN) may account-or
differences in the pathogenic properties of some retroviruses
(3, 4). For example, the thymotropic leukemogenic SL3-3
MuLV and the nonleukemogenic AKV MuLV contain a T
and C at position N, respectively. Mutation of the SL3-3
MuLV core site (TGTGGT_) to the sequence found in the
AKV MuLV core site (TGTGGTC) decreases transcription
from the SL3-3 MuLV enhancer specifically in T cells (3) and
alters the pathogenic properties of the SL3-3 virus (10).
Nuclear proteins that bind to distinct versions of the core
site have been detected (3), as have proteins that bind to
multiple core sites (3, 17-19). We have purified proteins from
calf thymus nuclei that bind to the core site in the Mo-MuLV
enhancer (TGTGGTA) (19). These proteins, which we call
core-binding factor (CBF), appear to be analogous to the
SL3-3 enhancer factor 1 (SEF1) characterized by Thornell et
al. (17, 18) and the SL3-3 and AKV MuLV CBF characterized by Boral et al. (3), which binds to multiple core sites
from mammalian type C retrovirus enhancers. CBF is probably also identical to the PEBP2 polyomavirus enhancerbinding proteins, which bind a core sequence (TGPyGGTPy)
in the polyomavirus enhancer (8).
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The core-binding factor (CBF) binds the conserved core motif in mammalian type C retrovirus enhancers.
We analyzed the phosphate contacts made by CBF on the Moloney murine leukemia virus enhancer by
ethylation interference assay. The phosphate contacts span 9 bp centered around the consensus core site. To
examine the sequence preferences for CBF binding, we employed the technique of selected and amplified
binding sequence footprinting (T. K. Blackwell and H. Weintraub, Science 250:1104-1110, 1990). The
consensus binding site for CBF defined by selected and amplified binding sequence footprinting is PyGPyG
GTPy.
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FIG. 1. Templates and primers used in SAAB analysis. The
sequence of the control probe is derived from the Mo-MuLV
enhancer, flanked by sequences for annealing PCR primers A and B.
The asterisk indicates the location of the 32P label. The locations of
restriction sites in the flanking sequences are underlined. The
position of the core site is indicated by the box. The sequence of the
random probe used in experiment 1 (Table 1) is shown, and the
locations of the four additional random positions in the probe used
in experiment 2 (Table 1) are indicated below the sequence.

erences.

An extensive mutagenic analysis of the core site by
Thomell et al. did not identify position 14 as a determinant
for SEFi binding (18). Thus, despite the preference for
cytosine at position 14 detected by SAAB footprinting, we
favor the interpretation that position 14 is outside the binding
site for CBF. However, we could not exclude the possibility
that position 14 is within the CBF binding site on the basis of
our SAAB footprinting data. Furthermore, since position 14
was the last random position on the probe, it was possible
that there are additional bases flanking position 14 which are
significant for CBF binding but were not tested. To address
these possibilities, we repeated the SAAB footprinting with
a probe that contained four additional random positions
(positions 15 to 18 [Table 1; data for experiment 2]). In this
experiment the distribution of bases at position 14 is random.
However, with this longer probe, preferences for a cytosine

dodecyl sulfate [SDS]), precipitated with ethanol, and amplified again by PCR as described above, with 32P-endlabeled primer A and unlabeled primer B. Following three
rounds of selection and amplification, the fragments were
digested with EcoRI and BamHI, gel purified, and subcloned
into the Bluescript SK+ phagemid. Inserts from 61 individual subclones were sequenced (12). The results of this
analysis are summarized in Table 1 (data for experiment 1).
The distribution of bases at positions 1 to 5 in the sites
defined by SAAB footprinting was random in experiment 1,
suggesting that positions 1 to 5 are outside the binding site

TABLE 1. CBF binding sites selected in vitro by SAAB footprinting
% of sitesa

Nucleotide
Position

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Expt 1

Consensus

Expt 2

Randomb

Moloney'

Pluralityd

G

A

T

C

G

A

T

C

N
N
N
N
N
N
G
N
G
G
N
N
N
N
N
N
N
N

A
T
A
T
C
T
G
T
G
G
T
A
A
G
C
A
G
T

A
T
A
T
C
T
G

48
55
50
17
26
3
100
0
100
100
0
0
42
18

36
15
34
15
6

5
21
6
23
31
65

11
9
10
45
31
26

76
2
2
10
70
2

6
2
2
12
11
83

4
2
1
10
11
10

2

34

64

0

8

87

2
0
15
0

95
92
37
8

3
8
6
74

14
94
95
58
8
4
100
5
100
100
1
2
6
29
11
42
6
2

2
2
12
14
4
6
0
1

93
69
80
31
70
8
4
8

2
27
2
25
17
43
90
88

F

G
G
T
C
A
A

G
C
A
G

12

N
N
N
N
N
Py
G
Py
G
G
T
Py
N
N
N
N
N
N

a Data for experiment 1 are percentages of sites in which the designated base appeared at each position in the binding site, from analysis of 61 independent
sequences. Data for experiment 2 are percentages of sites in which the designated base appeared at each position in the binding site, from analysis of 83
independent sequences. Data obtained with affinity-purified CBF and an individual subunit of CBF renatured from an SDS-polyacrylamide gel are combined.
b Random oligonucleotide pool from which CBF binding sites were selected in vitro.
Corresponding sequence from the Mo-MuLV enhancer.
d The nucleotide most commonly found at each position in mammalian type C retroviral enhancers (5).
' Thymine is found at position 8 in 89% of mammalian type C retroviral enhancers, and cytosine is found in the remaining 11%.
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for CBF. At positions 6 and 8, a pyrimidine is preferentially
selected. There is strong selection for thymines at positions
11 and 12. A random distribution of bases appears at position
13, while a cytosine is preferentially selected at position 14.
Affinity-purified preparations of CBF contain multiple
polypeptides that bind the core site (19). To determine
whether different sequences would be selected by individual
polypeptides, we repeated SAAB footprinting with several
CBF polypeptides that were first fractionated by SDSpolyacrylamide gel electrophoresis, eluted from individual
gel slices, and subjected to a denaturation-renaturation regimen (6, 19). The data from three independent peptides were
consistent with those obtained with the mixture of affinitypurified proteins, although the percentage of thymines versus cytosines selected at positions 6 and 8 was variable (data
not shown). We conclude that at least several of the polypeptides in the CBF preparation have similar binding pref-

_-A*
B --+

primer A

2409
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sequencing gel (Fig. 2A).
The methylation and ethylation interference data are summarized in Fig. 2B. CBF contacts six phosphates on the plus
strand and four phosphates on the minus strand of the
binding site. These phosphates map primarily to one face of
the DNA helix (we designate this the front face). The
phosphate contacts at positions 8 to 10 on the plus strand
wind around towards the back face of the DNA helix.
Positions 6 to 12, at which sequence preferences were
detected by SAAB footprinting, are within the area of
phosphate contacts.
The major groove between the two areas of phosphate
contacts on the front face of the helix contains the three
guanines contacted by CBF and SEF1 (positions 7, 9, and
10) (18, 19). Base contacts in the minor groove were also
detected by methylation interference at positions 11 to 13
(19). We propose that CBF contacts bases primarily in the
major groove between the two areas of phosphate contacts
on the front face of the helix. The contacts to adenines in the
minor groove could be generated by an arm of the polypeptide reaching into the minor groove, as seen for the engrailed
and MATaL2 homeodomain proteins (9, 21). Alternatively,
methylation at the N-3 atom of adenines 11 to 13 in the minor
groove could induce a conformational change in the DNA
which prevents CBF binding, or it could interfere with a
necessary conformational change induced in the DNA as a
result of CBF binding, such as narrowing of the minor
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FIG. 2. Ethylation interference of CBF on the Mo-MuLV enhancer. (A) Ethylation interference of CBF on a 45-bp region from
the Mo-MuLV enhancer. Lanes 1 to 4, top (plus) strand of the
Mo-MuLV enhancer; lanes 5 to 8, bottom (minus) strand. Lanes 1
and 5 and lanes 2 and 6 represent G and G+A chemical sequencing
tracts, respectively. Lanes 3 and 7 correspond to the protein-DNA
complex, and lanes 4 and 8 correspond to the free DNA bands from
the mobility shift gel. Vertical boxes indicate the location of the core
site. (B) Summary of ethylation and methylation interference results. In the upper portion is the B-form DNA helix showing the
phosphate and purine base contacts by CBF. Open squares with
letters (G or A) in the ladder represent bases in the CBF binding site
identified by methylation interference (19). Solid circles on the DNA
backbone represent phosphates identified as contacts for CBF by
ethylation interference. The numbers correspond to the positions
designated in Table 1. In the bottom portion, the phosphate contacts
are shown by arrowheads and the purine contacts are shown by
open circles above and below the sequence.

How does the consensus core site defined by SAAB
footprinting compare with core sites found in viral and

cellular enhancers? In 34 of 35 mammalian type C retroviral
enhancers, the bases found at positions 1 to 5 are 5'ATATC-3' (5). Since these sequences appear to be outside
the binding site for CBF defined by SAAB footprinting,
selective pressures other than CBF binding must maintain
the conservation of bases at positions 1 to 5 in retroviral
enhancers. At position 6, a thymine is present in 100% of
type C retroviral enhancers and in 76% of the sites selected
by CBF in vitro. Core sites in retroviral enhancers contain a
pyrimidine at position 8, as do the core sites identified by
SAAB. However, cytosine occurs at position 8 in 77% of the
core sites selected by SAAB in vitro but in only 11% of
retroviral enhancers. A thymine at position 11 is found in 35
of 35 retroviral enhancers (5), as well as in the consensus site
defined by SAAB footprinting. At position 12, a thymidine
appears in 5 of 35 retroviral enhancers (14%) but much more
frequently in the sites selected by SAAB footprinting (79%).
In fact, an adenine is more often found at position 12 in
mammalian type C retroviral enhancers (31%), including the
Mo-MuLV enhancer, yet an adenine at position 12 was
rarely selected in vitro. The frequency at which a thymine
appears at position 12 in the in vitro selected sites suggests
that CBF binds with a higher affinity to core sites with a
thymine at this position. This is consistent with data from
Thornell et al. for the protein SEF1, which we believe may
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at positions 17 and 18 and a guanine at positions 2 and 3 are
apparent. We cannot explain these preferences, nor can we
explain the variability with which they occur in different
probes. We speculate that perhaps the bases that are preferentially selected at these positions were overrepresented
in the original oligonucleotide pool.
When we analyze the data from both probes and include
only those bases that are consistently selected in defining a
consensus binding site for CBF, we derive the sequence
PyGPyGGTPy. This sequence is within the consensus highaffinity binding site for SEF1 (TICfi(iJTA) defined by
Thornell et al. (18).
The phosphate contacts for CBF were identified by ethylation interference analysis (13). Phosphate triester formation with N-ethyl-N-nitrosourea adds an ethyl group and
removes a negative charge from the DNA backbone. Inhibition of CBF binding by phosphate ethylation can be due to
steric interference or disruption of an electrostatic interaction between CBF and the DNA backbone. Probes
were prepared from a plasmid which contains Hae1117949Hae17994 sequences from the wild-type Mo-MuLV enhancer (numbered as described by Weiss et al. [20])
subcloned into the SmaI site of SP64 (14). The HaeIII7949HaeIII7994 probe was prepared by cutting the SP64 polylinker at either the EcoRI or the BamHI site, dephosphorylating the 5' end with calf intestinal phosphatase (Boehringer
Mannheim Biochemicals), end labeling with [y-32PJATP, and
recutting with either BamHI or EcoRI. The probes were
modified on phosphates with N-ethyl-N-nitrosourea (Sigma),
as described by Siebenlist and Gilbert (13). Binding reaction
mixtures (75-,u total volume) contained 100,000 cpm of
end-labeled ethylated probe and 10 Rl of affinity-purified
CBF. The binding and electrophoresis conditions were identical to those described previously for methylation interference (19). Purified DNA from the protein-DNA complex and
free DNA bands from the native polyacrylamide gel were
cleaved by alkali (13). The cleavage products were analyzed
by electrophoresis through a 15% polyacrylamide-7 M urea

groove.
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be identical to CBF on the basis of its tissue distribution and
sequence specificity (17-19). We note that several of the
highly thymotropic MuLVs including SL3-3 and Gross passage A, have a thymine at position 12. What advantage is
conferred to the Moloney virus by an adenine at position 12
is unclear. We note, however, that the SAAB analysis may
detect extremely small differences in binding specificity and
that these have uncertain, if any, functional significance.
Core sites with the sequence TGTGGTT are also found in
functionally important regions of the enhancers from several
cellular genes transcribed in T cells, including the T-cell
receptor ,B-, y-, and b-chain genes, the immunoglobulin
,u-chain gene, and the CD3 e-chain gene (11, 16, 18, 19). A
mutation in the core site in the T-cell receptor b-chain
enhancer significantly attenuates transcription of this gene in
T cells (11).
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